Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- probenecid
- Spectracef (cefditoren)
Interactions between your drugs
probenecid cefditoren
Applies to: probenecid, Spectracef (cefditoren)
Like other beta-lactam antibiotics, the coadministration with probenecid may increase the plasma concentrations of cefditoren pivoxil. The mechanism is competitive inhibition by probenecid of the renal tubular secretion of these antibiotics. According to the manufacturer, a single dose of probenecid increased the mean peak plasma concentration (Cmax), area under the concentration-time curve (AUC) and half-life of a single dose of cefditoren pivoxil by 49%, 122% and 53%, respectively. While this interaction may be exploited to enhance the antibacterial effect of cefditoren pivoxil, the potential for toxicity should be considered if the normal dosage of cefditoren pivoxil is administered with probenecid. A reduced dosage of cefditoren pivoxil may be required.
References (1)
- (2001) "Product Information. Spectracef (cefditoren)." TAP Pharmaceuticals Inc
Drug and food interactions
cefditoren food
Applies to: Spectracef (cefditoren)
ADJUST DOSING INTERVAL: Food enhances the oral absorption and bioavailability of cefditoren pivoxil. According to the manufacturer, administration of cefditoren pivoxil following a high-fat meal increased the mean peak plasma concentration (Cmax) and area under the concentration-time curve (AUC) by 50% and 70%, respectively, compared to administration in the fasting state. The absolute bioavailability of cefditoren pivoxil is approximately 14% under fasting conditions and 16% when given with a low-fat meal.
MANAGEMENT: To ensure maximal oral absorption, cefditoren pivoxil should be administered with or immediately after a meal.
References (1)
- (2001) "Product Information. Spectracef (cefditoren)." TAP Pharmaceuticals Inc
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Zyloprim
Zyloprim is used for calcium oxalate calculi with hyperuricosuria, gout, hyperuricemia secondary to ...
Uloric
Uloric (febuxostat) reduces the production of uric acid in your body and is used to treat gout ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Krystexxa
Krystexxa (pegloticase) is an enzyme that metabolizes uric acid and is used to treat chronic gout ...
Benemid
Benemid is used for adjunct to antibiotic therapy, gout, gouty arthritis
Aloprim
Aloprim is used for calcium oxalate calculi with hyperuricosuria, gout, hyperuricemia secondary to ...
Allopurinol
Allopurinol is used to treat gout or kidney stones, and to decrease levels of uric acid in certain ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.